Related Experiment Videos
DNA tumor vaccines
1The Wistar Institute, Philadelphia, PA 19104, USA.
Abstract:
A new generation of vaccines are being developed to induce immune responses that fight off infectious agents, or erradicate cancerous cells. These new vaccines are based on a plasmid vector, which in transfected mammalian cells cause constitutive high-level expression of the target antigen. Expression of the target antigen, in turn, can induce a full-range of immunologic responses, including cell-mediated killing, cell-mediated cytokine release and the production of antigen-specific antibodies. Through molecular techniques, these nucleic acid vaccines can be enhanced to increase target antigen expression and facilitate antigen presentation. Additionally, genetic adjuvants expressed simultaneously with the target antigens can induce the immune responses to disease-associated antigens. The ease with which these genetic vaccines can be generated and the potency of their ability to generate immune-mediated responses make them highly effective, which creates hope for developing effective treatment and prevention of various diseases, most notably cancer.
Insights
New nucleic acid vaccines utilize plasmid vectors for high-level antigen expression, stimulating robust immune responses for disease prevention and treatment, including cancer therapy.
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Background:
- Novel vaccines are emerging to combat infectious diseases and cancer.
- These vaccines leverage plasmid vectors for sustained, high-level expression of target antigens in mammalian cells.
Purpose of the Study:
- To summarize the development and potential of nucleic acid vaccines.
- To highlight their mechanisms for inducing comprehensive immune responses.
Main Methods:
- Utilizing plasmid vectors for antigen expression in mammalian cells.
- Employing molecular techniques to enhance antigen expression and presentation.
- Co-expressing genetic adjuvants to broaden immune responses.
Main Results:
- Constitutive high-level expression of target antigens is achieved.
- A full spectrum of immunologic responses, including cell-mediated immunity and antibody production, is induced.
- Enhanced antigen expression and presentation facilitate more potent immune activation.
Conclusions:
- Nucleic acid vaccines offer a versatile platform for generating potent immune responses.
- Their ease of generation and effectiveness provide hope for treating and preventing various diseases, particularly cancer.